Rizatriptan-Mepha oro 10 mg, Schmelztabletten - 12 Tablette(n) Swissmedic Key 65799004 CM Registration Holder Mepha Pharma AG Name Rizatriptan-Mepha oro 10 mg, Schmelztabletten Date of registration 22.05.2015 Original/Generic Generic Introduction of Sequence 22.05.2015 ATC-Classification Rizatriptan (N02CC04) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.05.10. Show package size 12 Tablette(n) Index Therapeuticus (Swissmedic) 02.05.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 39.29 Limitation No Deductible 10 % Consumer price 59.15 Feedback FB Daily cost GTIN 7680657990041 Medication Code Synthetika Pharmacode 6146549 Disponibility
Composition rizatriptanum 10 mg ut rizatriptani benzoas, mannitolum 174.07 mg, cellulosum microcristallinum, maltodextrinum, silica colloidalis anhydrica, crospovidonum, saccharinum natricum corresp. natrium 0.07 mg, aromatica, amylum modificatum, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Melting tablets Active Agent Dose Rizatriptan 10 mg
BAG: Active Agent Dose Rizatriptan 10 mg
Inactive agents Dose Amylum Modificatum Aromatica Cellulosum Microcristallinum Crospovidonum Magnesii Stearas Maltodextrine Mannitol 174.07 mg Pro Compresso Saccharinum Natricum Silica Colloidalis Anhydrica
Source Data was imported : 04.02.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
